Press Release

ZEISS Vision Care Acquires Vivior Assets to Advance Visual Behaviour Measurement and Personalized Eye Care

30 March 2026

Aalen, Germany | 30 March 2026 | ZEISS Vision Care

ZEISS Vision Care is dedicated to protecting and enhancing vision and lifelong visual health for consumers around the world. To further advance personalized vision solutions and improve eye health, data-driven insights play a crucial role. In line with this strategy, the company now announces the acquisition of key assets of Vivior AG, a Swiss-based innovator in digital health technologies for eye care, thereby strengthening its research capabilities and innovation potential in this rapidly evolving field.

Driving Innovation in Eye Care

Vivior’s technology specialises in monitoring and analysing visual behaviour, providing critical data that enables eye care professionals to deliver highly individualized solutions. By integrating Vivior’s intellectual property, platforms, and data analytics, ZEISS will accelerate the development of advanced tools for vision analysis, patient monitoring, and lens design.

Meeting Modern Eye Health Challenges

Modern lifestyles and increased digital device usage have transformed visual behaviour, creating new challenges for eye health. Leveraging Vivior’s technology, ZEISS Vision Care aims to:

  • Measure real-world visual behaviour for more accurate lens designs 
  • Enable hyper-personalized lens solutions tailored to individual needs and habits 
  • Support proactive eye health management, including myopia control and digital eye strain reduction  

Customer Benefits and Transition

Existing Vivior customers will experience a seamless transition, with continued service and support now under the ZEISS umbrella. ZEISS will further strengthen Vivior’s platforms to ensure a secure, reliable foundation for the future, enhancing the experience for both professionals and consumers.

A Vision for the Future

This acquisition strengthens ZEISS’ position in digital health and reinforces our commitment to innovative, data-driven solutions for better vision. By combining ZEISS’ expertise in optics with behavioural data insights, we are setting a new standard for personalized eye care.

Press Contact Sarah Kopp

ZEISS Vision Care

About ZEISS

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totalling almost 12 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, and Consumer Markets (September 30, 2025).

For its customers, ZEISS develops, produces, and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses, and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare, and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 15 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.

With over 46,600 employees, ZEISS is active globally in around 50 countries with more than 60 sales and service locations, around 40 research and development facilities, and 30 production facilities worldwide (September 30, 2025). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Further information at www.zeiss.com

 

ZEISS Vision Care

ZEISS Vision Care, part of ZEISS Consumer Markets segment, develops and manufactures comprehensive solutions for the entire value chain of ophthalmic optics. The portfolio includes top-quality eyeglass lenses, partner programs, ophthalmic instruments, services, digital solutions and apps for both eye care professionals and consumers, as well as care products for the eye and beyond. As one of the world's leading manufacturers of eyeglass lenses and the best-known prescription eyeglass lens brand amongst consumers worldwide, ZEISS is focused on optimal visual comfort and individualized vision solutions. With a passion for innovation and quality, ZEISS Vision Care is committed to protecting and enhancing people's vision and contributing to lifelong visual health.


Share this article


  • 1

    Footnote